The Patent Finder

Cao Pharmaceuticals Inc.

Also on record
Records under this name other than the patents Cao Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to Cao Pharmaceuticals Inc.

PatentTitleStatus Expires Confidence
US 6,699,875Cascade esters of camptothecins and methods of treating cancer using these compounds
Term ended
Term ended May 9, 2022 · From the USPTO record
Term endedTerm ended May 9, 2022From the USPTO record
US 6,703,399Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
Term ended
Term ended May 9, 2022 · From the USPTO record
Term endedTerm ended May 9, 2022From the USPTO record
US 6,228,855Aromatic esters of camptothecins and methods to treat cancers
Term ended
Term ended Aug 3, 2019 · From the USPTO record
Term endedTerm ended Aug 3, 2019From the USPTO record
US 6,352,996Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
Term ended
Term ended Aug 3, 2019 · From the USPTO record
Term endedTerm ended Aug 3, 2019From the USPTO record
US 6,407,239Aromatic esters of camptothecins and methods to treat cancers
Term ended
Term ended Aug 3, 2019 · From the USPTO record
Term endedTerm ended Aug 3, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited